Mark Weinreb, CEO and Chairman of the Board at BioRestorative Therapies, Inc. (BRTX), bought 6,300 shares at $0.29 ($2K) on 2019-08-22, disclosed to the SEC on 2019-08-23.
Open-market purchase of $2k BRTX by CEO and Chairman of the Board. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.24 | 2,000 | $480 | 29.1% |
| 2 | $0.26 | 1,300 | $338 | 20.5% |
| 3 | $0.26 | 1,300 | $339 | 20.6% |
| 4 | $0.29 | 1,700 | $493 | 29.9% |
| Total | $0.26 avg | 6,300 | $2K | 100% |
| Filing → |